v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 16,730,441 $ 20,581,313
Accounts receivable 8,489 12,510
Prepaid expenses 936,068 598,367
Other current assets 973,979 786,642
Total Current Assets 18,648,977 21,978,832
Property and equipment, net 4,807,729 4,911,077
Operating lease right-of-use assets 739,015 383,551
Intangible assets, net 151,314 216,876
Total Assets 24,347,035 27,490,336
Current Liabilities    
Accounts payable 2,602,351 1,542,457
Accrued liabilities 3,236,981 3,828,501
Deferred revenue 10,000,000 12,512
Management and directors' fees payable 74,261 71,303
Current portion of long-term debt 1,085,089 797,855
Current portion of finance lease liabilities 44,293 48,958
Current portion of operating lease liabilities 241,838 171,166
Current portion of grant repayable 65,814 43,100
Total Current Liabilities 17,350,627 6,515,852
Long-term debt, net of current portion 1,743,156 2,270,767
Finance lease liabilities, net of current portion 447,880 511,086
Operating lease liabilities, net of current portion 519,485 217,305
Grant repayable, net of current portion 206,785 253,221
Total Liabilities 20,267,933 9,768,231
STOCKHOLDERS' EQUITY    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 53,846,973 shares and 53,772,261 shares, respectively 53,847 53,772
Additional paid-in capital 156,441,677 154,730,938
Accumulated other comprehensive income 244,519 148,326
Accumulated deficit (152,272,367) (136,988,636)
Total VolitionRx Limited Stockholders' Equity 4,467,676 17,944,400
Non-controlling interest (388,574) (222,295)
Total Stockholders' Equity 4,079,102 17,722,105
Total Liabilities and Stockholders' Equity $ 24,347,035 $ 27,490,336

Source